Clinical updates, including trial initiations, enrollment status and data readouts and publications: Algernon, Altamira, Biohaven, Biorestorative, Bridgebio, Curocell, Cytokinetics, Daiichi, Day One, Dermata, Dompe, G1, Inhibikase, Kangpu, Optinose, Plus, Promore, Regulus, Revelation, Sanofi, Scancell, Selecta, Surrozen, Veralox.